Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

dc.date.accessioned	2023-03-06T07:31:52Z
dc.date.available	2023-03-06T07:31:52Z
dc.date.issued	2023
dc.identifier.citation	BMC Cancer. 2023 Feb 10;23(1):136. doi: 10.1186/s12885-023-10609-8.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100033
dc.relation.isversionof	10.1186/s12885-023-10609-8
dc.relation.isversionof	10.1186/s12885-023-10609-8
dc.title	Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
dc.relation.journal	BMC Cancer
dc.identifier.doi	10.1186/s12885-023-10609-8
dc.contributor.author	Karacin C
dc.contributor.author	Karacin C
dc.contributor.author	Oksuzoglu B
dc.contributor.author	Demirci A
dc.contributor.author	Keskinkılıç M
dc.contributor.author	Baytemür NK
dc.contributor.author	Yılmaz F
dc.contributor.author	Selvi O